GeneTX Biotherapeutics, LLC   Report issue

For profit Phase 2
Founded: Sarasota FL United States (2017)
Status: Acquired by Ultragenyx Inc. (2022)

Organization Overview

First Clinical Trial
2020
NCT04259281
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GeneTX Biotherapeutics, LLC